Evidence map›Paper›PMID 40241097›Full record

ArticleMolecular brain2025

Intravenous infusion of mesenchymal stem cells increased axonal signal intensity in the rubrospinal tract in spinal cord injury.

Ryosuke Hirota, Masanori Sasaki, Atsushi Teramoto, Toshihiko Yamashita, Jeffery D Kocsis, Osamu Honmou

Abstract read
In one paragraph

Article in Molecular brain, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ryosuke HirotaDepartment of Neural Regenerative Medicine, Institute of Regenerative Medicine, Sapporo Medical University School of Medicine, S1W17, Chuo-ku, Sapporo, 060-8556, Hokkaido, Japan.
Masanori SasakiDepartment of Neural Regenerative Medicine, Institute of Regenerative Medicine, Sapporo Medical University School of Medicine, S1W17, Chuo-ku, Sapporo, 060-8556, Hokkaido, Japan. msasaki@sapmed.ac.jp.
Atsushi TeramotoDepartment of Orthopaedic Surgery, Sapporo Medical University School of Medicine, Sapporo, 060-8556, Japan.
Toshihiko YamashitaDepartment of Orthopaedic Surgery, Sapporo Medical University School of Medicine, Sapporo, 060-8556, Japan.
Jeffery D KocsisDepartment of Neurology, Yale University School of Medicine Neurology, PO BOX 208018, New Haven, Connecticut, 06510, USA.
Osamu HonmouDepartment of Neural Regenerative Medicine, Institute of Regenerative Medicine, Sapporo Medical University School of Medicine, S1W17, Chuo-ku, Sapporo, 060-8556, Hokkaido, Japan.

Funding

Japan Society for the Promotion of Science 21K09231Japan Society for the Promotion of Science 22K09361Japan Society for the Promotion of Science 23K08547
6 · The paper itself

Abstract

Limited spontaneous recovery occurs after spinal cord injury (SCI). However, current knowledge indicates that multiple forms of axon growth in spared axons can lead to circuit reorganization. Intravenous infusion of mesenchymal stem cells (MSCs) provides functional improvements after SCI with an increased axonal network. In this study, we examined how intravenous infusion of MSCs facilitates axonal connections in the rubrospinal tract (RST), one of the significant descending tracts, using AAV neuronal tracing techniques. Our finding demonstrated that infused MSCs significantly enhanced axonal signal intensity in the RST, not only around the injury site but also in the rostral and caudal regions, suggesting that neural circuit reorganization is facilitated.

Indexed as

AxonsMesenchymal Stem CellsMesenchymal Stem Cell TransplantationSpinal Cord InjuriesAnimalsFemaleInfusions, IntravenousRats, Sprague-DawleyAxon tracingMesenchymal stem cellSpinal cord injury

Identifiers

PMID40241097
PMCPMC12004759

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.